Search research articles
Contact Us
Filters
Showing results (1-10 of 73) with videos related to
Page
of 8
Sort By:
Receptors & Clinical Investigation
|
May 26, 2015
The pERK of being a target: Kinase regulation of the orphan nuclear receptor ERRγ
Rebecca B Riggins
Endocrinology
|
September 22, 2023
Targeting the NAD+ Salvage Pathway: Synergistic Therapeutic Strategy for ER+ Metastatic Breast Cancer
Rebecca B Riggins, Suman Ranjit
Cell Cycle (Georgetown, Tex.)
|
December 16, 2014
ERRβ splice variants differentially regulate cell cycle progression
Mary Mazzotta Heckler, Rebecca B Riggins
Molecular Cancer Research : MCR
|
March 11, 2022
Unlocking the Mysteries of Lobular Breast Cancer Biology Needs the Right Combination of Preclinical Models
Shaymaa Bahnassy, Matthew J Sikora, Rebecca B Riggins
Drug News & Perspectives
|
July 18, 2009
The role of X-box binding protein-1 in tumorigenicity
Ayesha N Shajahan, Rebecca B Riggins, Robert Clarke
The Journal of Biological Chemistry
|
May 13, 2003
Synergistic promotion of c-Src activation and cell migration by Cas and AND-34/BCAR3
Rebecca B Riggins, Lawrence A Quilliam, Amy H Bouton
Journal of the Endocrine Society
|
January 20, 2025
Value of Peer Mentoring in Advancing Science Careers: Lessons Learned From NR Impact
Zeynep Madak-Erdogan, Rebecca B Riggins, Matthew J Sikora
Molecular Cancer Therapeutics
|
January 20, 2005
The nuclear factor kappa B inhibitor parthenolide restores ICI 182,780 (Faslodex; fulvestrant)-induced apoptosis in antiestrogen-resistant breast cancer cells
Rebecca B Riggins, Alan Zwart, Ruchi Nehra, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
May 15, 2015
ERRγ target genes are poor prognostic factors in Tamoxifen-treated breast cancer
Subha Madhavan, Yuriy Gusev, Salendra Singh, et al.
Endocrinology
|
January 7, 2021
Making an IMPACT on career development for early- and mid-career faculty
Matthew J Sikora, Rebecca B Riggins, Zeynep Madak-Erdogan
Page
of 8
Search research articles
Search
Showing results (1-10 of 73) with videos related to
Sort By:
Page
of 8
Receptors & Clinical Investigation
|
May 26, 2015
The pERK of being a target: Kinase regulation of the orphan nuclear receptor ERRγ
Rebecca B Riggins
Endocrinology
|
September 22, 2023
Targeting the NAD+ Salvage Pathway: Synergistic Therapeutic Strategy for ER+ Metastatic Breast Cancer
Rebecca B Riggins, Suman Ranjit
Cell Cycle (Georgetown, Tex.)
|
December 16, 2014
ERRβ splice variants differentially regulate cell cycle progression
Mary Mazzotta Heckler, Rebecca B Riggins
Molecular Cancer Research : MCR
|
March 11, 2022
Unlocking the Mysteries of Lobular Breast Cancer Biology Needs the Right Combination of Preclinical Models
Shaymaa Bahnassy, Matthew J Sikora, Rebecca B Riggins
Drug News & Perspectives
|
July 18, 2009
The role of X-box binding protein-1 in tumorigenicity
Ayesha N Shajahan, Rebecca B Riggins, Robert Clarke
The Journal of Biological Chemistry
|
May 13, 2003
Synergistic promotion of c-Src activation and cell migration by Cas and AND-34/BCAR3
Rebecca B Riggins, Lawrence A Quilliam, Amy H Bouton
Journal of the Endocrine Society
|
January 20, 2025
Value of Peer Mentoring in Advancing Science Careers: Lessons Learned From NR Impact
Zeynep Madak-Erdogan, Rebecca B Riggins, Matthew J Sikora
Molecular Cancer Therapeutics
|
January 20, 2005
The nuclear factor kappa B inhibitor parthenolide restores ICI 182,780 (Faslodex; fulvestrant)-induced apoptosis in antiestrogen-resistant breast cancer cells
Rebecca B Riggins, Alan Zwart, Ruchi Nehra, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
May 15, 2015
ERRγ target genes are poor prognostic factors in Tamoxifen-treated breast cancer
Subha Madhavan, Yuriy Gusev, Salendra Singh, et al.
Endocrinology
|
January 7, 2021
Making an IMPACT on career development for early- and mid-career faculty
Matthew J Sikora, Rebecca B Riggins, Zeynep Madak-Erdogan
Page
of 8